As CD4+ Th17 cells, γδ+ T cells, and ILCs are major IL-17 producers in the tumor microenvironment in the gut15, we investigated the cellular source of IL-17, which contributed to the overall increase in IL-17 levels seen in myeloid-miR-146a−/− mice during CRC. Here, IL17A is linked to neoplasm.